Mortality in young adults following in utero and childhood exposure to arsenic in drinking water

Environmental Health Perspectives

Volumn 120, Issue 11, 2012, Pages 1527-1531

  Smith, Allan H ^a   Marshall, Guillermo ^b,c   Liaw, Jane ^a   Yuan, Yan ^a   Ferreccio, Catterina ^b   Steinmaus, Craig ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Escuela de Medicina   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Childhood exposure; Chile; Drinking water; Environmental exposure; In utero; Mortality

Indexed keywords

ARSENIC; DRINKING WATER;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLADDER CANCER; BRONCHIECTASIS; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; ARSENIC; CHILD; CHILE; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84868566169     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104867     Document Type: Article

References (41)

1. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, et al. 2010. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376(9737):252-258.
2. Boffetta P, Tredaniel J, Greco A. 2000. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ Health Perspect 108:73-82.
3. CASEN. 1990. Illa Encuestra CASEN (Caracterizacion Socio Economica Nacional). Santiago, Chile:Ministerio de Planificacion y Cooperacion Nacional Republica de Chile.
4. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, et al. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153(5):411-418.
5. Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. 2004. Does arsenic exposure increase the risk for liver cancer? J Toxicol Environ Health A 67(19):1491-1500.
6. Chiu HF, Yang CY. 2005. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan. J Toxicol Environ Health A 68(5):319-327.
7. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. 1998. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44(2):185-190.
8. Gobierno de Chile, Ministerio de Salud. 2003. Resultados 1 Encuesta de Salud. Available: http://epi.minsal.cl/epi/html/invest/ENS/InformeFinalENS.pdf [accessed 24 August 2012].
9. Gobierno de Chile, Ministerio de Salud. 2010. Encuesta Nacional de Salud Chile 2009-2010. Available: http://www.minsal.gob.cl/portal/url/item/bcb03d7bc28b64dfe040010165012d23.pdf [accessed 19September 2012].
10. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, ChakrabortyD, et al. 1998. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 27(5):871-877.
11. Guha Mazumder DN, Steinmaus C, Bhattacharya P, vonEhrenstein OS, Ghosh N, Gotway M, et al. 2005. Bronchi-ectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 16(6):760-765.
12. Henderson SO, Haiman CA, Wilkens LR, Kolonel LN, Wan P, Pike MC. 2007. Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One 2(4):e377; doi:10.1371/journal.pone.0000377 [Online 18 April 2007].
13. Instituto Nacional de Estadisticas Chile. 2002. National Census 2002. Available: http://www.ine.cl/cd2002/index.php [accessed 23August 2012].
14. International Agency for Research on Cancer. 2004. Some Drinking-water Disinfectants and Contaminants, including Arsenic. IARC Monogr Eval Carcinog Risks Hum 84:1-477.
15. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, SmithAH. 2008. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev 17(8):1982-1987.
16. Marshall G, Ferreccio C, Yuan Y, Bates M, Steinmaus C, SelvinS, et al. 2007. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99(12):920-928.
17. McKay CP, Friedmann EI, Gomez-Silva B, Caceres-VillanuevaL, Andersen DT, Landheim R. 2003. Temperature and moisture conditions for life in the extreme arid region of the Atacama desert: four years of observations including the ElNiño of 1997-1998. Astrobiology 3(2):393-406.
18. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, ArmstrongGT, et al. 2008. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100(19):1368-1379.
19. Morgenstern H. 1995. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 16:61-81.
20. National Research Council. 1999. Arsenic in Drinking Water. Washington, DC:National Academy Press.
21. National Research Council. 2001. Arsenic in Drinking Water: 2001 Update. Washington, DC:National Academy Press.
22. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, SodaM, et al. 2008. Solid cancer incidence in atomic bomb survivors exposed inutero or as young children. JNatl Cancer Inst 100(6):428-436.
23. Reichard S. 1996. Ideology drives health care reforms in Chile. J Public Health Policy 17(1):80-98.
24. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, ZhangL. 2010. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 119:11-19.
25. Selvin S. 1995. Poisson regression analysis. In: Practical Biostatistical Methods. Belmont, CA:Duxbury Press, 455-496.
26. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol 147(7):660-669.
27. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296.
28. Sohel N, Persson LA, Rahman M, Streatfield PK, Yunus M, EkströmEC, et al. 2009. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology 20(6):824-830.
29. Soto R, Torche A. 2004. Spatial inequality, migration, and economic growth in Chile. Cuadernos de Economia 41:401-424.
30. Steinmaus C, Yuan Y, Liaw J, Smith AH. 2009. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology 20(6):807-815.
31. Tokar EJ, Diwan BA, Ward JM, Delker DA, Waalkes MP. 2011. Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci 119(1):73-83.
32. Vahter M. 2008. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol 102(2):204-211.
33. Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, HussainI, et al. 2002. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ 80(9):732-737.
34. Venturino P. 1991. Determinacion de concentracion de arsenico urinario en diferentes regiones de Chile. In: Primera Jornada Sobre Arsenicismo Laboral y Ambiental (Ministerio de Salud. Servicio de salud Antofagasta, Departamento de programas sobre el ambiente yACdS, ed). Antofagasta, Chile:Republica de Chile, 49-52.
35. Vineis P, Airoldi L, Veglia P, Olgiati L, Pastorelli R, Autrup H, et al. 2005. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 330(7486):277; doi:10.1136/bmj.38327.648472.82 [Online 3February 2005].
36. Waalkes MP, Liu J, Diwan BA. 2007. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 222(3):271-280.
37. World Health Organization. 1978. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death: Based on the Recommendations of the Ninth Revision Conference, 1975, and Adopted by the Twenty-ninth World Health Assembly, Vol1. Geneva:World Health Organization.
38. World Health Organization. 1992. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva:World Health Organization.
39. Yorifuji T, Tsuda T, Grandjean P. 2010. Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder [Letter]. J Natl Cancer Inst 102(5):360-361.
40. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, LiawJ, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed Region II of Chile from 1950 to 2000. Am J Epidemiol 166(12):1381-1391.
41. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, LiawJ, et al. 2010. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 21(1):103-108.